newsfilter
← Latest News
GlobeNewswire·

argenx to Report Half Year 2026 Financial Results and Second Quarter Business Update on July 23, 2026

  • argenx will host a conference call & audio webcast on Thursday, July 23, 2026 at 2:30 p.m. CET (8:30 a.m. ET).
  • The event will discuss the company's half-year 2026 financial results & provide a second quarter business update.
  • The live webcast is accessible via the Investors section of argenx.com/investors, with a replay available for approximately one year.
  • Dial-in numbers are provided for the United States, Canada, Belgium, France, Netherlands, United Kingdom, Japan, & Switzerland.
  • Participants must use access code 3810049 & dial in 15 minutes prior to the call.
  • argenx is a global immunology company developing novel antibody-based medicines, including the first approved FcRn blocker.